Afatinib 30 mg in the treatment of common and uncommon EGFR-mutated advanced lung adenocarcinomas: a retrospective, single-center, longitudinal study - Qian, Jie; Ye, Xuanting; Huang, Aimi; Qin, Ruoyan; Cai, Yuqing; Xue, Yiqian; Zhang, Shi; Wang, Weimin; Xiong, Liwen; Gu, Aiqin (Journal of Thoracic Disease, 2022)